MediPharm Labs (MLZ) Stock Statistics & Valuation Metrics
Total Valuation
MediPharm Labs has a market cap or net worth of EUR 16.32M. The enterprise value is EUR 20.36M.
- Market Cap
- EUR 16.32M
- Enterprise Value
- EUR 20.36M
Share Statistics
MediPharm Labs has 427,177,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 427,177,150
- Owned by Insiders
- 9.51%
- Owned by Institutions
- ―
Financial Efficiency
MediPharm Labs’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -23.35%.
- Return on Equity (ROE)
- -0.23
- Return on Assets (ROA)
- -0.18
- Return on Invested Capital (ROIC)
- -23.35%
- Return on Capital Employed (ROCE)
- -0.23
- Revenue Per Employee
- 355.31K
- Profits Per Employee
- -65.09K
- Employee Count
- 127
- Asset Turnover
- 0.99
- Inventory Turnover
- 3.89
Valuation Ratios
The current PE Ratio of MediPharm Labs is -5.17. MediPharm Labs’s PEG ratio is -0.08.
- PE Ratio
- -5.17
- PS Ratio
- 0.62
- PB Ratio
- 0.72
- Price to FCF
- -26.70
- Price to Operating Cash Flow
- -28.46
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, MediPharm Labs had revenue of 45.12M and earned -8.27M in profits. Earnings per share was -0.02.
- Revenue
- 45.12M
- Gross Profit
- 13.97M
- Operating Income
- -8.41M
- Pretax Income
- -8.27M
- Net Income
- -8.27M
- EBITDA
- -6.54M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -897.00K and capital expenditures -63,000, giving a free cash flow of -960.00K billion.
- Operating Cash Flow
- -897.00K
- Free Cash Flow
- -960.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
MediPharm Labs pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.46%
- Earnings Yield
- -17.98%
Stock Price Statistics
- Beta
- -0.31
- 52-Week Price Change
- -19.51%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 39.69
- Average Volume (3m)
- 2,910
Important Dates
MediPharm Labs upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
MediPharm Labs as a current ratio of 2.77, with Debt / Equity ratio of 0.56%
- Current Ratio
- 2.77
- Quick Ratio
- 1.96
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 1.62
- Interest Coverage Ratio
- -133.46
Taxes
In the past 12 months, MediPharm Labs has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
MediPharm Labs EV to EBITDA ratio is -5.23, with an EV/FCF ratio of -19.10.
- EV to Sales
- 0.44
- EV to EBITDA
- -5.23
- EV to Free Cash Flow
- -19.10
- EV to Operating Cash Flow
- -20.44
Balance Sheet
MediPharm Labs has EUR 9.85M in cash and marketable securities with EUR 421.00K in debt, giving a net cash position of EUR 9.43M billion.
- Cash & Marketable Securities
- EUR 9.85M
- Total Debt
- EUR 421.00K
- Net Cash
- EUR 9.43M
- Net Cash Per Share
- EUR 0.02
- Tangible Book Value Per Share
- EUR 0.08
Margins
Gross margin is 34.30%, with operating margin of -12.49%, and net profit margin of -12.00%.
- Gross Margin
- 34.30%
- Operating Margin
- -12.49%
- Pretax Margin
- -12.00%
- Net Profit Margin
- -12.00%
- EBITDA Margin
- -8.45%
- EBIT Margin
- -12.27%
Analyst Forecast
The average price target for MediPharm Labs is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -12.20%
- EPS Growth Forecast
- 46.72%
